Medical Devices APAC

APAC Acute Care Needleless Connectors Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

APAC Acute Care Needleless Connectors Market Analysis Industry Trends and Forecast to 2034: Segmented by (By Mechanism, By Connector Type, By End User, By Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $111.9 Mn Placeholder estimate
Estimate 2025 $121.7 Mn 21.5% of the global market
Projected 2034 $259.4 Mn 113.1% Adds $137.7 Mn over 9 forecast years
CAGR 2025–2034 8.77% Faster than 40% of 180 Medical Devices markets here
Key players 7 +2
  • APAC is 21.5% of the global market.
  • Among regions, the largest is North America at $277.9 Mn.
  • Fastest growing: Africa at 9% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$137.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Acute Care Needleless Connectors Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $111.9 Mn — —
2025 (base) $121.7 Mn +$9.8 Mn —
2026 (forecast) $132.4 Mn +$10.7 Mn +8.8%
2027 (forecast) $144.0 Mn +$11.6 Mn +18.3%
2028 (forecast) $156.7 Mn +$12.6 Mn +28.7%
2029 (forecast) $170.4 Mn +$13.7 Mn +40%
2030 (forecast) $185.3 Mn +$14.9 Mn +52.2%
2031 (forecast) $201.6 Mn +$16.3 Mn +65.6%
2032 (forecast) $219.3 Mn +$17.7 Mn +80.1%
2033 (forecast) $238.5 Mn +$19.2 Mn +95.9%
2034 (forecast) $259.4 Mn +$20.9 Mn +113.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Acute Care Needleless Connectors Market Analysis at a glance
Market size, 2025$121.7 Mn placeholder estimate
Forecast, 2034$259.4 Mn placeholder estimate
Growth (CAGR), 2025–20348.77% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsMechanism, connector type and end user (see all)
Key playersB. Braun Melsungen AG, Baxter International, BD (Becton, Dickinson), Cardinal Health, CareFusion Corporation and 2 more (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Acute Care Needleless Connectors Market Executive Summary

Acute Care Needleless Connectors are medical devices that are used to establish access points to tips of vascular catheters for introducing fluids as well as drawing out material without necessarily using needles. These connectors are important, particularly in the acute care, to reduce patient risk and protect staff from needle stick injuries.

The acute care needleless connectors market has grown because there is a need to minimize Healthcare-Associated Infections and conform to the regulatory requirements. These devices are used to avoid complications such as needle-stick injuries, especially in acute-care situations including hospitals and emergency departments. North America dominates the market, while the Asia-Pacific region is the fastest-growing, attributed to increasing healthcare expenditures. Integration of new technologies, increased concern for the safety of patients and allowing market competition has its advantages while such factors as high price and specificity of use may cause obstacles to creating a successful market in some areas. Some of the market leaders are ICU Medical, BD, and B. Braun.

Bar chart: Asia Pacific Acute Care Needleless Connectors market size, 2024–2034, placeholder estimates. $111.9 Mn in 2024, $121.7 Mn in 2025 and $259.4 Mn in 2034, 8.77% CAGR.
Asia Pacific Acute Care Needleless Connectors market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Acute Care Needleless Connectors Market Dynamics

Market Growth Drivers

New needleless connector designs are also improving performance and reducing risk of infection, including the issue of efficient fluid displacement. The key factors that are propelling the demand for these devices are the increasing expenditure on healthcare across the globe and the governments having strict policies related to cases of diseases. There is an increasing awareness of the value and application of these technologies among the healthcare professionals, due to their ability to prevent situations like needle stick injuries or cases of catheter related bloodstream infections (CRBSI). These connectors are getting popular in intravenous administration of medicines and blood sampling.

Opportunity

There are future prospects for applications of the needleless connectors to increase its usage in hospitals, clinics, and homecare as they opt for enhanced patient safety. Technological developments in the connector designs and the materials used, especially for better displacement of fluid and infection control, are imperative for the future growth of the market. Furthermore, the increase in global healthcare spending, especially in the developed nations, and the expansion in demand in the emergent nations with a quickly progressing healthcare sector are additional opportunities within the market.

Market Restraints

Lack of adequate training on the use of these devices may lead to wrong application and increased problems like infection transmission and catheter-related bloodstream infections (CRBSI). The designs of some connectors can in fact be intricate and this can also discourage their use because small intricate connectors are hard to use especially during emergencies such as in emergency department. However, some factors that still restrain the market rise include the fact that sophisticated systems are expensive, and due to these costs, some institutions especially in the developing world may opt for the low-end varieties.

Competitive Landscape for Acute Care Needleless Connectors Market in APAC

Key Players

Recent Developments

March 2024, Medtronic Neurosurgery Recalled Duet External Drainage and Monitoring System Catheter Tubing due to a Potential for the Catheter Disconnection from the Patient Line Stopcock Connectors.

December 2025, B. Braun Medical Inc., a leader in smart infusion therapy and pain management, announced the launch of its new CARESITE MicroTM Luer Access Device, designed to reduce exposure to harmful chemicals and decrease infection risk, making IV access for patients and healthcare providers.

October 2025, The PIVO™ Pro Needle-free Blood Collection Device is designed to achieve the first and only compatibility with integrated and long peripheral IV catheters, including the new Nexiva™ Closed IV Catheter System with NearPort™ IV Access in addition to traditional short IV catheters.

August 2021, PuraCath Medical, a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced that it has received 510(k) clearance for its FireFly Needleless Connector from the USFDA. The Firefly Needleless Connector is a sterile single patient use connector for needleless access to the IV line and IV catheter during IV therapy and can be used for direct injection, intermittent infusion, continuous infusion or aspiration.

Healthcare Policies and Regulatory Landscape for Acute Care Needleless Connectors Market in APAC

Acute Care Needleless Connectors in APAC: rules and payment

In some of the countries we cover here, medical devices are regulated by TGA (Australia)⁠[1], NMPA (China)⁠[2], MDACS (Hong Kong)⁠[3], CDSCO (India)⁠[4], PMDA (Japan)⁠[5], MDA (Malaysia)⁠[6], Medsafe (WAND) (New Zealand)⁠[7], FDA Philippines (Philippines)⁠[8], HSA (Singapore)⁠[9], Thai FDA (Thailand)⁠[10], Ministry of Health (Indonesia)⁠[11], DRAP (Pakistan)⁠[12], MFDS (South Korea)⁠[13] and Ministry of Health (Vietnam)⁠[14]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[15], basic medical insurance (China)⁠[16], the Hospital Authority (Hong Kong)⁠[17], Ayushman Bharat PM-JAY (India)⁠[18], public health insurance (Japan)⁠[19], subsidised public care (Malaysia)⁠[20], Pharmac (New Zealand)⁠[21], PhilHealth (Philippines)⁠[22], MediShield Life (Singapore)⁠[23], the Universal Coverage Scheme (Thailand)⁠[24], JKN (BPJS Kesehatan) (Indonesia)⁠[25], out of pocket and Sehat Sahulat (Pakistan)⁠[26], National Health Insurance (South Korea)⁠[27] and social health insurance (Vietnam)⁠[28].

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Medical Device Division, Department of Health. Checked 14 Nov 2026.

[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[6] Medical Device Authority. Checked 14 Nov 2026.

[7] Medsafe. Checked 14 Nov 2026.

[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[9] Health Sciences Authority. Checked 14 Nov 2026.

[10] Thai Food and Drug Administration. Checked 14 Nov 2026.

[11] Ministry of Health of Indonesia. Checked 19 Nov 2026.

[12] Drug Regulatory Authority of Pakistan (DRAP). Checked 19 Nov 2026.

[13] Ministry of Food and Drug Safety. Checked 19 Nov 2026.

[14] Ministry of Health of Vietnam. Checked 19 Nov 2026.

[15] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[16] National Healthcare Security Administration. Checked 14 Nov 2026.

[17] Hospital Authority. Checked 14 Nov 2026.

[18] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[19] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[20] Ministry of Health Malaysia. Checked 14 Nov 2026.

[21] Pharmac. Checked 14 Nov 2026.

[22] PhilHealth. Checked 14 Nov 2026.

[23] CPF Board, MediShield Life. Checked 14 Nov 2026.

[24] National Health Security Office. Checked 14 Nov 2026.

[25] BPJS Kesehatan. Checked 19 Nov 2026.

[26] Ministry of National Health Services, Regulations and Coordination. Checked 19 Nov 2026.

[27] Health Insurance Review and Assessment Service (HIRA). Checked 19 Nov 2026.

[28] Vietnam Social Security. Checked 19 Nov 2026.

Policy changes and Reimbursement scenario

Needleless connectors are being prescribed in institutions by virtue of Policy/Regulation modification from OSHA among others which recommend the use of needleless connectors in a bid to reduce needlestick injuries and improve patient outcomes. Other measures related to infection control by governments and health organizations also contribute to the need for safer medical devices, propelling the demand for needleless connectors. Furthermore, funding programs in some parts of the globe help healthcare centres to purchase such sophisticated instruments. With regards to reimbursement, changes in insurance policies and transitions to value-based care systems are encouraging the use of needleless connectors by eliminating or decreasing costs. Research on the cost-saving impact that averaged decreased infections and improved patient experiences could widen insurance acceptance and coverage.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Acute Care Needleless Connectors right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Acute Care Needleless Connectors in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Acute Care Needleless Connectors market in Asia Pacific?
Placeholder estimate: about $121.7 Mn in 2025, rising to about $259.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Acute Care Needleless Connectors market in Asia Pacific growing?
Placeholder estimate: about 8.77% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Acute Care Needleless Connectors market report cover?
The report splits the market by mechanism (Positive Fluid Displacement, Negative Fluid Displacement, Neutral Fluid Displacement), connector type (Simple Needleless Connectors, Complex Needleless Connectors) and end user (Hospitals, Clinics and Ambulatory Settings, Others).
Who are the key players in the Acute Care Needleless Connectors market?
Key players include B. Braun Melsungen AG, Baxter International, BD (Becton, Dickinson), Cardinal Health, CareFusion Corporation and ICU Medical, among 7 companies the report profiles.
What is driving the Acute Care Needleless Connectors market?
New needleless connector designs are also improving performance and reducing risk of infection, including the issue of efficient fluid displacement.
How much research is published on Acute Care Needleless Connectors?
PubMed lists 67 papers on Acute Care Needleless Connectors added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 9 Nov 2026.
Back to Catalogue

Related Medical Devices reports in APAC

See all

Related on hospital and infectious diseases

See the topic